• BV6 IAP Antagonist: Optimizing Apoptosis and Radiosensitizat

  2026-08-04

  BV6 empowers researchers with selective control over apoptosis in both cancer and endometriosis models, enabling precision radiosensitization and translational study design. This guide details best-practice experimental workflows, data-driven troubleshooting, and actionable protocol enhancements to maximize the impact of APExBIO’s BV6.

• Hexa His Tag Peptide: Precision Tools for Immunoprecipitatio

  2026-08-04

  Explore the scientific foundations and advanced applications of Hexa His tag peptide in immunoprecipitation and protein purification. This article offers expert insight into competitive elution strategies and assay design, uniquely connecting molecular mechanisms with practical workflow enhancements.

• Cyclosporin A: Mechanistic Leverage in Translational Immunol

  2026-08-03

  This thought-leadership article explores the mechanistic precision and translational strategy of Cyclosporin A, focusing on its dual action in immunosuppression and mitochondrial modulation. It synthesizes recent structural and functional evidence, provides actionable protocol guidance, and positions APExBIO’s Cyclosporin as a research-grade benchmark. The article enriches the conversation by bridging mechanistic insights with workflow translation, pushing beyond standard product summaries.

• FLOT1–FOSL2–EphA2 Axis Drives Pro-Inflammatory Microglia in

  2026-08-03

  This study reveals that the interaction between FLOT1 and FOSL2 promotes EphA2 transcription, activating the p38/MAPK pathway and shifting microglia to a pro-inflammatory state in Alzheimer’s disease (AD). Disrupting this axis in AD mouse models reduces neuroinflammation and improves cognitive outcomes, highlighting a potential therapeutic target for modulating neurodegeneration.

• Molidustat (BAY85-3934): Optimizing HIF Stabilization in Ren

  2026-08-02

  Molidustat (BAY85-3934) is redefining erythropoietin stimulation by precisely targeting HIF-PH enzymes to treat chronic kidney disease anemia. This article delivers actionable guidance for bench researchers, including protocol parameters, troubleshooting, and translational insights built on the latest mechanistic evidence.

• Selective Autophagy Regulates IRF3 Stability in Antiviral Im

  2026-08-01

  Wu et al. reveal that selective autophagy, mediated by CALCOCO2/NDP52 and regulated by the deubiquitinase PSMD14, controls the degradation and stability of IRF3—an essential transcription factor for type I interferon production—during viral infection. This work clarifies the mechanisms that balance antiviral signaling and immune suppression, offering new perspectives for studying transcription factor regulation in immunity.

• Redefining Phosphorylation Analysis: Strategic Insights for

  2026-07-31

  This article bridges mechanistic advances in phosphorylation detection with translational strategy, highlighting how Phos binding reagent (Phosbind) acrylamide enables precise, antibody-free analysis in complex signaling contexts—drawing lessons from HCMV-FHL2 research and offering actionable guidance for researchers tackling dynamic protein phosphorylation.

• 3X (DYKDDDDK) Peptide: Workflow Optimization in Protein Rese

  2026-07-31

  The 3X (DYKDDDDK) Peptide enables highly sensitive and robust detection, purification, and structural analysis of FLAG-tagged proteins, surpassing conventional epitope tags in versatility and minimal interference. Discover practical workflow enhancements and troubleshooting strategies leveraging this advanced peptide in both standard and metal-sensitive applications.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-07-30

  Wang et al. (2024) identified a METTL16-SENP3-LTF signaling axis that confers resistance to ferroptosis and promotes tumorigenesis in hepatocellular carcinoma. This mechanistic discovery bridges m6A RNA modification with iron metabolism, providing new insight into therapeutic vulnerabilities for sensitizing HCC to ferroptotic cell death.

• Metabolic Intervention Amplifies Ferroptosis and Cuproptosis

  2026-07-30

  This study introduces a nanosystem-based metabolic intervention that enhances both ferroptosis and cuproptosis in tumor cells by targeting glycolysis and NAD+ metabolism. The findings demonstrate a promising approach to increase the efficacy of regulated cell death-based cancer therapies and boost anti-tumor immunity.

• Mapping Metabolite Regulation of TET2 via Biochemical and NM

  2026-07-29

  Zhang et al. introduce a robust protocol combining biochemical assays and saturation transfer difference (STD) NMR spectroscopy to systematically identify and validate metabolite regulators of human TET2 dioxygenase. This workflow advances mechanistic studies at the intersection of metabolism and epigenetic enzyme activity, offering a framework to dissect metabolic-epigenetic crosstalk.

• NADH in Mitochondrial Research: Protocols, Applications & Tr

  2026-07-29

  NADH (reduced nicotinamide adenine dinucleotide) is pivotal for high-fidelity mitochondrial research and disease modeling, offering precise control over cellular redox state and energy metabolism. This article explores optimized workflows, advanced applications, and troubleshooting strategies for using APExBIO’s NADH in experimental settings.

• Azilsartan (TAK-536): Precision AT1 Blockade in Neuroinflamm

  2026-07-28

  Azilsartan (TAK-536) stands out as a potent, specific AT1 receptor antagonist that enables researchers to dissect the renin-angiotensin system's role in neuroinflammation and cardiovascular pathways. Leveraging recent breakthroughs, this guide translates key experimental workflows, troubleshooting, and innovative findings into actionable protocols for advanced astrocyte–microglia studies.

• Dual-Action Kinase Inhibitors Promote p38α MAPK Dephosphoryl

  2026-07-28

  The referenced study reveals that certain kinase inhibitors not only block kinase activity but also actively promote dephosphorylation of p38α MAP kinase by stabilizing its activation loop in a conformation preferred by phosphatases. This dual-action mechanism suggests new strategies for designing more specific and potent kinase inhibitors, with broad implications for both basic research and therapeutic development.

• MMP7 Drives EMT and Fibrosis via E-cadherin/β-Catenin in Bil

  2026-07-27

  This study elucidates how matrix metalloproteinase 7 (MMP7) promotes liver fibrosis in biliary atresia by inducing epithelial–mesenchymal transition (EMT) through the E-cadherin/β-catenin pathway. The findings highlight MMP7 as a pivotal profibrotic factor and suggest therapeutic strategies targeting this axis for pediatric liver disease.

15896 records 1/1060 page Next 12345 下5页 Last page